• prodrug
  • NEW HAVEN, Conn., Nov. 2, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced a poster presentation detailing the preclinical profile of ACH-3422, a uridine-analog nucleotide prodrug being advanced for the potential treatment of chronic hepatitis C viral infection (HCV). (cnbc.com)
  • Novel
  • Recently, uridine adenosine tetraphosphate (Up 4 A) has been identified as a novel and potent endothelium-derived contracting factor (EDCF). (hindawi.com)
  • foods
  • Upon digestion of foods containing RNA, uridine is released from RNA and is absorbed intact in the gut. (mpbio.com)